Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

111.88
+0.46000.41%
Pre-market: 111.52-0.3606-0.32%08:22 EST
Volume:1.77M
Turnover:198.90M
Market Cap:220.97B
PE:19.06
High:112.82
Open:112.02
Low:111.79
Close:111.42
Loading ...
Jan 31, 2025

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 16, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 18, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 18, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Feb 15, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 31, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Sep 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
May 09, 2023

Correspondence

Form CORRESP - Correspondence